oxyphenbutazone has been researched along with Coronary Disease in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FOX, SL | 1 |
EISEN, MJ | 1 |
2 other studies available for oxyphenbutazone and Coronary Disease
Article | Year |
---|---|
POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS.
Topics: Anticoagulants; Blood Chemical Analysis; Chemical Phenomena; Chemistry; Coronary Disease; Gout; Hema | 1964 |
COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.
Topics: Arthritis; Coronary Disease; Geriatrics; Hemorrhage; Oxyphenbutazone; Phenylbutazone; Prothrombin Ti | 1964 |